Maximum Standardized Uptake Values on Positron Emission Tomography of Esophageal Cancer Predicts Stage, Tumor Biology, and Survival

Annals of Thoracic Surgery

Volumn 82, Issue 2, 2006, Pages 391-395

  Cerfolio, Robert J ^a   Bryant, Ayesha S ^b  

^a Kentucky   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER PATIENT; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; ELECTRONIC MEDICAL RECORD; ESOPHAGUS BIOPSY; ESOPHAGUS CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL RATE; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; ESOPHAGEAL NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES;

EID: 33746102928     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2006.03.045     Document Type: Article

References (14)

1. Sobin L.H., and Wittekind C. TNM Classification of malignant tumours. 6th ed. (2003), Wiley & Sons, New York
2. National Cancer Institute. physicians inquiry (2003). http://www.nci.gov Available at: www.nci.gov.
3. Lee J.R., Madsen M.T., Bushnel D., et al. A threshold method to improve standardized uptake value reproducibility. Nucl Med Comm 21 (2000) 685-690
4. Cerfolio R.J., Bryant A.S., Ojha B., et al. Improving the inaccuracies of clinical staging of patients with NSCLC. a prospective trial. Ann Thorac Surg 80 (2005) 1207-1213
5. Mountain C.F. Revisions in the international systems for staging lung cancer. Chest 111 (1997) 1710-1717
6. Van Westreenen H.L., Plukker J.T., Cobben D.C., et al. Prognostic value of the standardized uptake value in esophageal cancer. AJR Am J Roentgenol 185 (2005) 436-440
7. Nabi H.A., and Zubeldia J.M. Clinical applications of F18-FDG in oncology. J Nucl Med Technol 30 (2002) 3-9
8. Cerfolio R.J., Bryant A.S., Ojha B., et al. The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy. J Thorac Cardiovasc Surg 129 (2005) 1232-1241
9. Cox D.R. Regression models and life-tables. J R Stat Soc 34 (1972) 187-220
10. Wijnhoven B.P., Pignatelli M., Dinjens W.N., et al. Reduced p120ctn expression correlates with poor survival in patients with adenocarcinoma of the gastroesophageal junction. J Surg Oncol 92 (2005) 116-123
11. Yamazaki K., Hasegawa M., Ohoka I., et al. Increased E2F-1 expression via tumour cell proliferation and decreased apoptosis are correlated with adverse prognosis in patients with squamous cell carcinoma of the oesophagus. J Clin Pathol 58 (2005) 904-910
12. Takita K.H., Myazaki T., Nakajima M., et al. Correlation of 18-F-flourodeoxyglucose (FDG) accumulation with glucose transporter (Glut-1) expression in esophageal squamous cell carcinoma. Anticancer Res 23 (2003) 3263-3272
13. Sasaki R., Komaki R., Macapinlac H., et al. [18F] Fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer. J Clin Oncol 23 (2005) 6799-6800
14. Cerfolio R.J., Bryant A.S., Ojha B., et al. The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence and survival. J Thorac Cardiovasc Surg 130 (2005) 151-159